lilioa85
Lv2
170 积分
2022-10-20 加入
-
Discovery of D6808, a Highly Selective and Potent Macrocyclic c-Met Inhibitor for Gastric Cancer Harboring MET Gene Alteration Treatment
12天前
已完结
-
Plasma ddPCR for the detection of MET amplification in advanced NSCLC patients: a comparative real-world study
26天前
已完结
-
MET alterations in advanced non-small cell lung cancer
1个月前
已完结
-
Perioperative Immune Checkpoint Inhibition in Early-Stage Non–Small Cell Lung Cancer
2个月前
已完结
-
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
2个月前
已完结
-
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
2个月前
已完结
-
SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection
3个月前
已完结
-
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study
4个月前
已完结
-
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study
4个月前
已完结
-
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer
4个月前
已完结